Johnson & Johnson

A panel of U.S. health advisers has endorsed booster doses of Johnson & Johnson’s COVID-19 vaccine

Johnson & Johnson says a booster shot of its COVID-19 vaccine appears to produce “a rapid and robust” increase in antibodies needed to fight the virus

Around 760,000 doses were allocated to Illinois before the pause, 290,000 were administered

A U.S. health panel says it’s time to resume use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots

The McHenry County Department of Health plans to use partnerships with local home health care agencies and the Illinois National Guard to vaccinate medically homebound residents against COVID-19

Johnson & Johnson’s COVID-19 vaccine will remain in limbo a while longer after U.S. health advisers told the government Wednesday that they need more evidence to decide if a handful of unusual blood clots were linked to the shot

Health authorities are investigating highly unusual blood clots after use of two COVID-19 vaccines, and a rare immune response is the main suspect